Recommendations, benefits and risks of prostate cancer screening – Dr. Matthew Tollefson скачать в хорошем качестве

Recommendations, benefits and risks of prostate cancer screening – Dr. Matthew Tollefson

Men ages 55 to 69 should talk with their health care provider about prostate-specific antigen (PSA)–based screening for prostate cancer. That's according to new recommendations from the U.S. Preventive Services Task Force (USPSTF). Mayo Clinic urologist Dr. Matthew Tollefson says, "The recommendations don't change for men over 70. If men over 70 are asymptomatic with no family history, they don't' need to have PSA tests every year. Those men have very low risk of dying from prostate cancer. But for men who are from 55 to 69, there can be a benefit seen with screening. This is where the task force is now giving nuance to the discussion, and saying there isn't a blanket statement for everyone." More health and medical news on the Mayo Clinic News Network http://newsnetwork.mayoclinic.org/